Petros Pharmaceuticals, Inc.

PTPI · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,710$13,337$9,426$23,848
Short-Term Investments$0$0$0$0
Receivables$416$2,226$2,110$3,064
Inventory$2,999$1,610$1,815$520
Other Curr. Assets$169$3,217$1,316$3,111
Total Curr. Assets$7,294$20,390$14,668$30,543
Property Plant & Equip (Net)$137$255$398$525
Goodwill$0$0$0$0
Intangibles$3,204$8,972$12,244$25,293
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$4,178$5,111$11,029
Total NC Assets$3,341$13,405$17,753$36,847
Other Assets$0$0$0$0
Total Assets$10,635$33,796$32,421$67,390
Liabilities
Payables$2,329$1,713$1,806$4,558
Short-Term Debt$7,311$1,282$1,232$0
Tax Payable$0$0$0$0
Deferred Revenue$0$2,048$0-$126
Other Curr. Liab.$8,388$5,728$4,030$26,422
Total Curr. Liab.$18,028$10,771$7,068$30,980
LT Debt$75$6,995$8,651$405
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$3,550$0$460
Total NC Liab.$75$10,545$8,651$865
Other Liabilities$0$0$0$0
Cap. Leases$138$263$405$405
Total Liabilities$18,103$21,316$15,719$31,845
Equity
Pref Stock$0$409$0$0
Common Stock$1$0$0$2
Retained Earnings-$113,208-$98,890-$90,726-$70,689
AOCI$0$0$0$0
Other Equity$105,740$110,960$107,429$106,234
Total Equity-$7,468$12,480$16,702$35,545
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$10,635$33,796$32,421$67,390
Net Debt$3,676-$5,060$457-$23,443
Petros Pharmaceuticals, Inc. (PTPI) Financial Statements & Key Stats | AlphaPilot